当前位置: X-MOL 学术Pediatr. Dermatol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Experience using dupilumab for pediatric atopic dermatitis at a tertiary care c enter: Inadequate response and adverse events
Pediatric Dermatology ( IF 1.2 ) Pub Date : 2021-09-13 , DOI: 10.1111/pde.14799
Paige L McKenzie 1, 2 , Sneha Rangu 1 , James R Treat 1, 3 , Leslie Castelo-Soccio 1, 3
Affiliation  

Dupilumab is highly effective in treating atopic dermatitis (AD). However, some patients experience difficulties with dupilumab therapy, such as inadequate clinical response, failure to achieve long-term disease control, or adverse events (AEs). Our objective is to assess inadequate response and AEs occurring in children on dupilumab therapy for AD.

中文翻译:

在三级医疗机构 c 中使用 dupilumab 治疗小儿特应性皮炎的经验:反应不足和不良事件

Dupilumab 在治疗特应性皮炎 (AD) 方面非常有效。然而,一些患者在接受 dupilumab 治疗时遇到困难,例如临床反应不足、未能实现长期疾病控制或不良事件 (AE)。我们的目标是评估在 AD 中接受 dupilumab 治疗的儿童中发生的反应不足和 AE。
更新日期:2021-11-09
down
wechat
bug